US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist
  • 3.290
  • +0.205+6.65%
Close May 9 16:00 ET
  • 3.310
  • +0.020+0.61%
Post 19:57 ET
299.52MMarket Cap-8024P/E (TTM)

About Aquestive Therapeutics Company

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Company Profile

SymbolAQST
Company NameAquestive Therapeutics
Listing DateJul 25, 2018
Issue Price15.00
Founded2004
CEOMr. Daniel Barber
MarketNASDAQ
Employees135
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address30 Technology Drive
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-941-1900
Websitehttp://www.aquestive.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel Barber
  • Chief Executive Officer, President and Director
  • 2.50M
  • Lori J. Braender
  • Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
  • 1.19M
  • Stephen Wargacki
  • Chief Science Officer
  • --
  • A. Ernest Toth, Jr
  • Chief Financial Officer
  • 1.12M
  • Dr. Carl N. Kraus, M.D.
  • Chief Medical Officer
  • --
  • A. Mark Schobel
  • Chief Innovation and Technology Officer
  • --
  • Peter Boyd
  • Senior Vice President, Information Technology, Human Resources and Communications
  • --
  • Cassie Jung
  • Senior Vice President, Operations
  • --
  • John S. Cochran
  • Vice Chairman of the Board
  • 137.23K
  • Dr. Gregory B. Brown,M.D.
  • Chairman of the Board
  • 150.77K
  • Santo J. Costa
  • Independent Director
  • 202.16K
  • Abigail L. Jenkins, M.S.
  • Independent Director
  • --
  • Dr. Marco Taglietti,M.D.
  • Independent Director
  • 121.78K
  • Timothy E. Morris
  • Independent Director
  • 145.23K
  • Dr. Julie Krop, M.D.
  • Independent Director
  • 137.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg